Funded

Biomère/Jubiles
Equities - IR 2022

  • Good health & well being
  • Industry, innovation and infrastructure
  • Responsible consumption and production
Impact category Sustainable living Degree of maturity Acceleration
Amount collected : € 573 840.00

Pitch

Presentation

Jubiles presents itself as an acronym for "Jus Bio Local et Solidaire". Today, the brand is positioned on kombucha, a finely sparkling beverage made from fermented tea. It was born from the research of François, co-founder, to find the perfect and healthy recipe by combining fermented tea and fresh, non-stabilized, seasonal fruit juices. Kombucha is an original beverage with therapeutic virtues, produced locally from natural ingredients, and whose distribution is carried by the company Biomère, specialized in the sale of organic drinks since 2017. It is now present in 1,500 specialized organic outlets (Biocoop, La Vie Claire, Naturalia...) but also in supermarkets (Monoprix, Carrefour Market...), thus ensuring the influence of these products. Now, Biomère wishes to widen its target to promote on a large scale another possibility of consumption respectful of human health and the environment. The first citizen fundraising carried by LITA.co had already raised 160k€ to launch the activity in 2018. From now on, Jubiles intends to stand out against traditional sodas by offering an alternative food model to that of junk food. That's why the kombucha brand is raising €600K today, including €200K reserved for LITA.co, with the aim of acquiring new premises, increasing its production and developing commercially on a regional (and then national) scale by strengthening an already well-established brand identity.

Invest in Biomère and participate in democratizing the consumption of healthy drinks for the environment and health!

Biomère en levée de fonds sur LITA.co !
1/2

Follow the project on:

Transaction

Reasons to invest

Register or sign in to LITA.co and complete your account to see the information available on this page.
Amount collected
€ 573 840
Financial product
Shares
Co-investors
Investing in unlisted companies carries the risk of losing all the money invested.